The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer-Reference-Cited by-同舟云学术

The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer

Published:2008-12 Issue:1 Volume:8 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Weber Achim,Kristiansen Ilka,Johannsen Manfred,Oelrich Beibei,Scholmann Katharina,Gunia Sven,May Matthias,Meyer Hellmuth-Alexander,Behnke Silvia,Moch Holger,Kristiansen Glen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-8-369.pdf

Reference25 articles.

1. Davis-Smyth T, Duncan RC, Zheng T, Michelotti G, Levens D: The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators. J Biol Chem. 1996, 271 (49): 31679-31687.

2. Ring HZ, Vameghi-Meyers V, Min H, Nikolic JM, Black DL, Francke U: The mouse Fubp gene maps near the distal end of chromosome 3. Genomics. 1999, 56 (3): 357-358.

3. Ring HZ, Vameghi-Meyers V, Nikolic JM, Min H, Black DL, Francke U: Mapping of the KHSRP gene to a region of conserved synteny on human chromosome 19p13.3 and mouse chromosome 17. Genomics. 1999, 56 (3): 350-352.

4. He L, Liu J, Collins I, Sanford S, O'Connell B, Benham CJ, Levens D: Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J. 2000, 19 (5): 1034-1044.

5. Liu J, He L, Collins I, Ge H, Libutti D, Li J, Egly JM, Levens D: The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell. 2000, 5 (2): 331-341.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FUBP1 in human cancer: Characteristics, functions, and potential applications;Translational Oncology;2024-10

2. FUSE binding protein1 interacts with Tumor Suppressor p53 and p53-Isoforms through their DNA Binding domain: Mapping the FBP1 binding site;2023-08-31

3. Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity;Oncogene;2023-08-03

4. Far upstream element‐binding protein 1 confers lobaplatin resistance by transcriptionally activating PTGES and facilitating the arachidonic acid metabolic pathway in osteosarcoma;MedComm;2023-05-09

5. FUSE binding protein1 interacts with Tumor Suppressor p53 and p53-Isoforms through their DNA Binding domain: Mapping the FBP1 binding site;Indian Journal of Biochemistry and Biophysics;2023